methylprednisolone acetate has been researched along with Graves Ophthalmopathy in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sisti, E | 2 |
| Coco, B | 2 |
| Menconi, F | 2 |
| Leo, M | 2 |
| Rocchi, R | 2 |
| Latrofa, F | 2 |
| Profilo, MA | 2 |
| Mazzi, B | 2 |
| Albano, E | 1 |
| Vitti, P | 2 |
| Marcocci, C | 2 |
| Brunetto, M | 2 |
| Marinò, M | 2 |
2 other studies available for methylprednisolone acetate and Graves Ophthalmopathy
| Article | Year |
|---|---|
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Chemi | 2015 |
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotra | 2015 |